BioCentury
ARTICLE | Company News

MediGene gains further Etomoxir rights

February 15, 2001 8:00 AM UTC

MediGene (NMarkt:MDG) gained additional rights from Wolf Research Pharmaceutical (Allensbach, Germany) to its cardiovascular compound, Etomoxir, for use in other indications. MDG, which had rights for...